BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 29128865)

  • 1. Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.
    Sun X; Yuan W; Hao F; Zhuang W
    Med Sci Monit; 2017 Nov; 23():5389-5395. PubMed ID: 29128865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.
    Pelosof L; Yerram S; Armstrong T; Chu N; Danilova L; Yanagisawa B; Hidalgo M; Azad N; Herman JG
    Epigenetics; 2017 Jul; 12(7):540-550. PubMed ID: 27918237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the utility of
    Nakasone ES; Zemla TJ; Yu M; Lin SY; Ou FS; Carter K; Innocenti F; Saltz L; Grady WM; Cohen SA
    Epigenetics; 2024 Dec; 19(1):2349980. PubMed ID: 38716804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Promoter Hypermethylation of
    Sugara M; Chowdappa R; Kumar KVV; Gawari R; Swamy SN; Kumar SS
    Indian J Surg Oncol; 2021 Sep; 12(3):454-459. PubMed ID: 34658570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis.
    Chen C; Zhu Y; Zhang H; Xiao L
    Gynecol Obstet Invest; 2024 Apr; ():1-13. PubMed ID: 38615670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.
    Salta S; P Nunes S; Fontes-Sousa M; Lopes P; Freitas M; Caldas M; Antunes L; Castro F; Antunes P; Palma de Sousa S; Henrique R; Jerónimo C
    J Clin Med; 2018 Nov; 7(11):. PubMed ID: 30405052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.
    Liu X; Zhang Y; Wu X; Xu F; Ma H; Wu M; Xia Y
    Front Pharmacol; 2022; 13():909821. PubMed ID: 35847022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-catenin signaling pathway is involved in induction of apoptosis by oridonin in colon cancer COLO205 cells.
    Bu H; Liu D; Cui J; Cai K; Shen F
    Transl Cancer Res; 2019 Sep; 8(5):1782-1794. PubMed ID: 35116929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome-Wide DNA Methylation Profiling in Colorectal Cancer and Normal Adjacent Colon Using Infinium Human Methylation 450K.
    Baharudin R; Ishak M; Muhamad Yusof A; Saidin S; Syafruddin SE; Wan Mohamad Nazarie WF; Lee LH; Ab Mutalib NS
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers.
    Riffet M; Eid Y; Faisant M; Fohlen A; Menahem B; Alves A; Dubois F; Levallet G; Bazille C
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction.
    Nassar FJ; Msheik ZS; Nasr RR; Temraz SN
    Clin Epigenetics; 2021 May; 13(1):111. PubMed ID: 34001239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook.
    Lianidou E
    Mol Oncol; 2021 Jun; 15(6):1683-1700. PubMed ID: 33942482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
    Yang C; Zhang Y; Lin S; Liu Y; Li W
    Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation-Based Therapies for Colorectal Cancer.
    Cervena K; Siskova A; Buchler T; Vodicka P; Vymetalkova V
    Cells; 2020 Jun; 9(6):. PubMed ID: 32599894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation detection methods used in colorectal cancer.
    Zhan YX; Luo GH
    World J Clin Cases; 2019 Oct; 7(19):2916-2929. PubMed ID: 31624740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection.
    Gao W; Pang D; Yu S
    J Int Med Res; 2019 May; 47(5):2116-2125. PubMed ID: 30922137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.
    He D; Yue Z; Li G; Chen L; Feng H; Sun J
    Med Sci Monit; 2018 Oct; 24():7475-7481. PubMed ID: 30341274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aloe-Emodin Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Colorectal Cancer Cells.
    Cheng C; Dong W
    Med Sci Monit; 2018 Sep; 24():6331-6339. PubMed ID: 30199885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.